Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Confidence Interval
100%
Hypercholesterolemia
100%
Bempedoic Acid
100%
Odds Ratio
33%
High-sensitivity C-reactive Protein (hs-CRP)
16%
Safety Profile
11%
Lipoprotein Particle number
11%
Randomized Controlled Trial
5%
Scopus
5%
PubMed
5%
Diabetes
5%
Cholesterol
5%
Google Scholar
5%
High-density Lipoprotein Cholesterol (HDL-C)
5%
MEDLINE
5%
Triglyceride Level
5%
Apolipoprotein B (Apo B)
5%
Low-density Lipoprotein Cholesterol (LDL-C)
5%
Prospero
5%
Decreased Risk
5%
Treatment Discontinuation
5%
Lipid Profile
5%
Control Arm
5%
Elevated Liver Enzymes
5%
Number of Individuals
5%
Serum Uric Acid
5%
Lipids
5%
C-reactive Protein Level
5%
Long-term Safety
5%
Apolipoprotein A-I (ApoA-I)
5%
Elevated Creatine Kinase
5%
Acceptable Safety
5%
First-in-class
5%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
5%
Lipid-lowering Drugs
5%
Serum Concentration
5%
Safety Analysis
5%
Low-density Lipoprotein Particle number
5%
Average Effect
5%
New Onset
5%
Plasma Lipids
5%
High-density Lipoprotein Particles
5%
Web of Science Database
5%
Neuroscience
Meta-Analysis
100%
C-Reactive Protein
100%
High Density Lipoprotein Cholesterol
66%
Randomized Controlled Trial
33%
Triacylglycerol
33%
Low-Density Lipoprotein
33%
High-Density Lipoprotein
33%
Apolipoprotein A
33%
Hypolipidemic Agent
33%
Liver Enzyme
33%
Creatine Kinase
33%
Apolipoprotein B
33%
Low Density Lipoprotein Cholesterol
33%
Uric Acid
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hypercholesterolemia
100%
Bempedoic Acid
100%
C Reactive Protein
42%
Randomized Controlled Trial
28%
High Density Lipoprotein Cholesterol
28%
High Density Lipoprotein
14%
Low Density Lipoprotein
14%
Triacylglycerol
14%
Apolipoprotein B
14%
Low Density Lipoprotein Cholesterol
14%
Uric Acid
14%
Creatine Kinase
14%
Antilipemic Agent
14%
Hypertransaminasemia
14%
Lipoprotein
14%
Apolipoprotein A
14%